SCHEMBL21031069

SCHEMBL21031069

Cc1ccc(-c2cnco2)c(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 12/20 0.59
LMNA P02545 1/20 0.53
PKM P14618 1/20 0.53
IMPDH1 P20839 4/20 0.50
NOTUM Q6P988 1/20 0.44
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
GAA P10253 1/20 0.41
TP53 P04637 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PTK2 Q05397 1/20 0.39
LTA4H P09960 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22598718 0.86 LMNA (0.53) IMPDH2LMNAPKMIMPDH1NOTUM
SCHEMBL2427867 0.79 LMNA (0.53) IMPDH2LMNAPKMIMPDH1GAA
SCHEMBL19823860 0.79 IMPDH2 (0.47) IMPDH2LMNAPKMIMPDH1NOTUM
SCHEMBL23493611 0.79 LMNA (0.53) IMPDH2LMNAPKMIMPDH1PTK2
SCHEMBL6170749 0.79 IMPDH2 (0.60) IMPDH2LMNAPKMIMPDH1NOTUM
SCHEMBL22188032 0.79 IMPDH2 (0.60) IMPDH2IMPDH1NOTUM
SCHEMBL23032430 0.79 IMPDH2 (0.47) IMPDH2LMNAPKMIMPDH1NOTUM
SCHEMBL8075634 0.77 IMPDH2 (0.70) IMPDH2IMPDH1
SCHEMBL16785595 0.76 LMNA (0.53) IMPDH2LMNAPKMIMPDH1NOTUM
SCHEMBL14267698 0.76 IMPDH2 (1.00) IMPDH2PKMIMPDH1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LIMITED (IN) 2019-09-12 US disclosed
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS LUPIN LTD (IN) 2019-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190275012-A9 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO IMPDH2 3740/4885LMNA 4835/4885PKM 4296/4885
US-20190160045-A1 SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS MALT1, PTP4A1, PTPRO IMPDH2 3740/4885LMNA 4835/4885PKM 4296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.